Changing the Way We Think About (and With) Antidepressants

Biol Psychiatry. 2018 Aug 15;84(4):e27-e28. doi: 10.1016/j.biopsych.2018.06.017.

Authors

Andrew M Novick¹, David A Ross²

Affiliations

¹ Mood Disorders Research Program and Laboratory for Clinical and Translational Neuroscience, Butler Hospital, Providence, Rhode Island; Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, Rhode Island. Electronic address: andrew_novick@brown.edu.
² Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut.

No abstract available

Publication types

Research Support, N.I.H., Extramural

MeSH terms

Antidepressive Agents, Second-Generation / pharmacology*
Citalopram / pharmacology*
Cognition / drug effects
Cognitive Behavioral Therapy
Depression / therapy*
Humans

Substances

Antidepressive Agents, Second-Generation
Citalopram

Grants and funding